...

首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >Impact of sex on clinical response in rheumatoid arthritis patients treated with biologics at approved dosing regimens (vol 60, pg S103, 2020)

【24h】

Impact of sex on clinical response in rheumatoid arthritis patients treated with biologics at approved dosing regimens (vol 60, pg S103, 2020)

机译：性对批准给药方案治疗生物制剂关节炎患者临床反应的影响（VOL 60，PG S103,2020）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology》 |2021年第3期|共1页
作者
Song Xuyang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Detection and clinical significance of rheumatoid factor, anti -CCP antibody, immunoglobulin and cytokines in serum of patients with rheumatoid arthritis [J] . Hui-Ya Zhu, Qian Feng 海南医科大学学报（英文版） . 2016,第024期
2. Correlation of hepcidin content with iron metabolism, inflammatory response and immune response in patients with rheumatoid arthritis combined with anemia [J] . Lan Tang, Yan Zhang, Hai-Yan Zhang 海南医科大学学报（英文版） . 2018,第016期
3. Correlation of hepcidin content with iron metabolism, inflammatory response and immune response in patients with rheumatoid arthritis combined with anemia [J] . Lan Tang, Yan Zhang, Hai-Yan Zhang 海南医科大学学报(英文版) . 2018,第016期
4. Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report (Retraction Article, vol 30, pg 24, 2020) (Retraction of Vol 30, Pg 24, 2020) [J] . Suzuki Yasuo, Sugiyama Naonobu, Fukuma Yuri, Modern rheumatology . 2020,第1期

机译：高剂量甲氨蝶呤的安全性和有效性（超过8毫克/周）在2838例日本类风湿性关节炎患者中：一款月刊监测报告（收缩制品，第30卷，PG 24,2020）（卷30，PG 24,2020）
5. Incidence of dose escalation and impact on biologic costs among patients with rheumatoid arthritis treated with three intravenous agents [J] . Nadkarni Anagha, McMorrow Donna, Patel Chad, Journal of comparative effectiveness research . 2017,第8期

机译：用三种静脉剂处理的类风湿性关节炎患者对剂量升级和对生物成本的影响
6. Incidence of dose escalation and impact on biologic costs among patients with rheumatoid arthritis treated with three intravenous agents [J] . Nadkarni Anagha, McMorrow Donna, Patel Chad, Journal of comparative effectiveness research . 2017,第8期

机译：用三种静脉剂处理的类风湿性关节炎患者对剂量升级和对生物成本的影响
7. Immunogenic HLA-DR-presented-peptides Identified from Clinical Samples of Synovial Tissue/Fluid and Peripheral Blood from Patients with Rheumatoid Arthritis or Lyme Arthritis [C] . Qi Wang, Elise E. Drouin, Chunxiang Yao, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：免疫原性HLA-DR呈递肽，从类风湿性关节炎或莱姆关节炎患者的滑膜组织/液体和外周血的临床样本中鉴定出来
8. Impact of Ultrasonography on Use of Biologics in Patients with Rheumatoid Arthritis [D] . Atzinger, Christopher B. 2018

机译：超声检查对类风湿关节炎患者使用生物制剂的影响
9. Extended report: Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month multicentre randomised double-blind placebo-controlled phase II clinical trial [O] . Tsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, -1

机译：扩展报告：地诺单抗对日本类风湿关节炎患者的影响：风湿性关节炎甲氨蝶呤患者中AMG 162（Denosumab）的剂量反应研究以验证其对骨侵蚀（DRIVE）的抑制作用-一项为期12个月的多中心随机研究双盲安慰剂对照的II期临床试验
10. Impact of Sex on Clinical Response in Rheumatoid Arthritis Patients Treated With Biologics at Approved Dosing Regimens [O] . Lanyan Fang, Xuyang Song, Ping Ji, 2020

机译：性别对批准给药方案生物制剂治疗的类风湿性关节炎患者的临床反应
11. Guidance for Industry. Clinical Development Programs for Drugs, Devices, and211 Biological Products for the Treatment of Rheumatoid Arthritis (RA) [R] . 1999

机译：工业指南。用于治疗类风湿性关节炎（Ra）的药物，设备和211生物制品的临床开发计划

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号